Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

HCPs-_Important information on safety and risk minimisation of Daratumumab and interference with Blood Compatability Testing

Inform health care professionals of the interference of Darzalex (daratumumab) with antibody screening and crossmatching

For Healthcare Professionals

Important Information about Blood Transfusions

Card for patient's receiving Darzalex (daratumumab)- patient should carry this card while receiving treatment and for 6 months after treatment has ended.

Important information on safety and risk minimisation of Daratumumab and Interference with Blood Compatibility Testing

Information for Blood Banks on the intereference with Antiglobulin Test _blood typing

For Healthcare Professionals

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.